Browsing by Subject "Tuberculosis treatment"
Now showing items 1-7 of 7
-
Assessment of factors affecting adherence to tuberculosis treatment in Northern Uganda : A case study of TB patients in Kitgum Hospital
(Makerere University, 2019-09-26)The study sought to Assess Factors Affecting Adherence to Tuberculosis Treatment in Northern Uganda, with the objective to: assess TB patients’ perceptions on adherence to treatment services; examine TB patients’ attitudes ... -
Comparison of models for analysis of time to loss to follow up and associated risk factors among patients receiving tuberculosis treatment from Mbarara Regional Referral Hospital, Uganda
(Makerere University, 2023)Background: Tuberculosis (TB) remains the top infectious killer worldwide. In Uganda, incidence of TB was reported at 200 per 100,000 people per year. Loss to follow up (LTFU) on TB treatment was 13% in Uganda and 10% in ... -
Factors affecting implementation of community based directly observed treatment of tuberculosis, short course, in Hoima district - Uganda.
(2009)Introduction: Tuberculosis is a communicable disease of human beings caused by Mycobacterium Tuberculosis bacteria. In CB-DOTS, tuberculosis patients are initially treated in a health centre by a health worker for two weeks ... -
Health service delay and associated factors among pulmonary tuberculosis patients presenting to Mulago Hospital: a cross sectional study.
(2009-10)Delay in the diagnosis of pulmonary tuberculosis (PTB) is common in many countries in sub-Saharan Africa. Timely diagnosis of active TB is particularly crucial to minimise not only morbidity and mortality in the community, ... -
A machine learning model to explore individual risk factors for tuberculosis treatment refill non-adherence in Mukono District.
(Makerere University, 2023-01)Despite the availability and implementation of well-known efficacious interventions for TB prevention and treatment by the Ministry of Health, Uganda (MoH), treatment non-adherence persists. Moreover, identifying a specific ... -
Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis
(Public Library of Science, 2012-06)Background: In Uganda, isoniazid plus ethambutol is used for 6 months (6HE) during the continuation treatment phase of new tuberculosis (TB) cases. However, the World Health Organization (WHO) recommends using isoniazid ... -
Urban movement and alcohol intake strongly predict defaulting from tuberculosis treatment: an operational study
(Public Library of Science, 2012-05-02)Background:High levels of defaulting from treatment challenge tuberculosis control in many African cities. We assessed defaulting from tuberculosis treatment in an African urban setting. Methods: An observational study ...